Hepcidin is a key iron regulatory hormone that controls expression of the iron exporter ferroportin to increase the iron supply when needed to support erythropoiesis and other essential functions, but to prevent the toxicity of iron excess. The bone morphogenetic protein (BMP)-SMAD signaling pathway, through the ligand BMP6 and the co-receptor hemojuvelin, is a central regulator of hepcidin transcription in the liver in response to iron. Here, we show that dietary iron loading has a residual ability to induce Smad signaling and hepcidin expression in Bmp6-/-mice, effects that are blocked by a neutralizing BMP2/4 antibody. Moreover, BMP2/4 antibody inhibits hepcidin expression and induces iron loading in wildtype mice, whereas a BMP4 antibody has no effect. Bmp2 mRNA is predominantly expressed in endothelial cells of the liver, where its baseline expression is higher, but its induction by iron is less robust than Bmp6. Mice with a conditional ablation of Bmp2 in endothelial cells exhibit hepcidin deficiency, serum iron overload, and tissue iron loading in liver, pancreas and heart, with reduced spleen iron. Together, these data demonstrate that in addition to BMP6, endothelial cell BMP2 has a non-redundant role in hepcidin regulation by iron.
| I N TR ODU C TI ON
Iron is an essential element for the basic functions of life, including mitochondrial respiration, DNA synthesis, and oxygen transport. 1 Iron deficiency reduces cell survival and is a global problem in human health. 1, 2 However, excess iron is also toxic by catalyzing the production of reactive oxygen species that can damage cells and tissues. 3 A clinical scenario including liver cirrhosis, hepatocellular cancer, cardiomyopathy, and diabetes mellitus characterizes diseases that lead to the accumulation of iron in humans, including hereditary hemochromatosis and iron loading anemias. 4, 5 For these reasons, iron concentration at the cellular and organismal level must be kept within a narrow range.
The peptide hormone hepcidin is a key regulator of systemic iron balance by mediating the degradation of the iron exporter ferroportin on the surface of duodenal enterocytes, macrophages, and hepatocytes to inhibit dietary iron absorption and iron recycling from body storage sites. 6 Hepcidin expression in the liver is controlled by stimulatory signals from iron and inflammation and inhibitory signals from erythropoietic drive. 6 One of the most important regulators of hepcidin expression is BMP6, 7, 8 a member of the TGF-b superfamily. BMP6 is produced in liver endothelial cells in response to iron loading 9, 10 and acts in a paracrine fashion on hepatocytes to bind the co-receptor hemojuvelin (HJV, also known as HFE2) and BMP type I and type II receptors to induce phosphorylation of SMAD1/5/8 proteins, which complex with SMAD4 and translocate to the nucleus to induce hepcidin transcription. 7, 11 The importance of BMP6 and the BMP-SMAD signaling pathway in hepcidin and iron homeostasis regulation is demonstrated by the finding that mutation or ablation of Bmp6, 7, 8 Previously, it was reported that iron is still able to stimulate hepcidin expression in global Bmp6 knockout (Bmp6-/-) mice, albeit to a lesser extent than in wildtype mice, suggesting the existence of a residual pathway for iron-mediated hepcidin expression in the absence of BMP6. 19 Moreover, HJV, the critical BMP co-receptor for hepcidin regulation, 11, 12 binds to several other BMP ligands with similar or higher affinity as BMP6, including BMP2. 20, 21 Here, we used Bmp6-/-mice, neutralizing BMP antibodies, and conditional Bmp2 knockout mice to investigate whether BMP2 contributes to hepcidin regulation and iron homeostasis.
| M A TE RI A L S A ND M E THOD S

| Animals
All animal protocols were approved by the Institutional Animal Care and antibody (MAB3552, R&D Systems) daily for three days. Control mice received an IP injection of an equal volume of phosphate buffered saline (PBS) using the same dosing regimen. Six hours after the last injection, mice were sacrificed and blood, livers, and spleen were harvested for measurement of iron parameters and hepcidin expression.
For Bmp6-/-mouse experiments, male and female Bmp6-/-mice were generated as previously described 9 and fed a low iron diet (2-6 ppm, Harlan Teklad) for 3 weeks upon weaning. Mice were then either kept on the low iron diet or switched to a standard rodent diet, which is high in iron (380 ppm), for 1 week without or with 4 IP injections of neutralizing BMP2/4 antibody (10 mg/kg body weight) or an equal volume of PBS alone, which were administered every other day. Animals were harvested 6 hours after the last injection.
For the iron challenge experiments, four-week-old C57BL/6 male mice were placed on a standard diet (380 ppm iron), a high iron diet containing 2% carbonyl iron (Harlan Teklad), or a low iron diet (2-6 ppm, Harlan Teklad) for 3 weeks. Alternatively, 129S6/SvEvTac male mice were placed on an iron sufficient diet (40 ppm, Research Diets) or high iron diet containing 1% carbonyl iron (10,000 ppm, Research Diets) for 4 weeks upon weaning.
| RNA isolation, reverse transcription, and qRT-PCR
Total liver RNA was isolated using QIAshredder and RNeasy purification kits (Qiagen), and cDNA was synthesized from 1000 ng RNA using the iScript cDNA synthesis kit (Bio-Rad). qRT-PCR was performed as described previously 24 using the Power SYBR Green PCR Master Mix (Life Technologies) and primers in Supporting Information Table S2 . Transcript copy numbers of Bmp2 and Bmp6 were determined using Taqman Universal Master Mix, TaqMan primers and probes selected to target all known mRNA variants (Applied Biosystems), and standard curves generated from the plasmids in Supporting Information Table S3 .
| Luciferase assay
Hepcidin promoter luciferase reporter assays in Hep3B cells were carried out using the Dual-Luciferase Reporter Assay System (Promega)
as previously described. 7, 11 In brief, Hep3B cells were transfected with 250 ng Hepcidin promoter luciferase reporter 11 
| Iron analysis
Serum iron and transferrin saturation were determined by colorimetric assay (Pointe Scientific) and quantitative tissue nonheme iron concentrations were determined by the method of Torrence and Bothwell as described previously. 24 Tissue iron is reported as lg iron/g wet weight tissue.
| Prussian blue staining
Tissues were fixed in neutral buffered formalin for 24 h, embedded in paraffin, sectioned at 7 lm, deparaffinized and rehydrated, and subjected to Perls' Prussian blue staining using an iron stain kit (American MasterTech). For tissues with less iron loading, a modified diaminobenzidine (DAB)-enhanced Perls' stain containing cobalt chloride was used. 25 2.6 | Hepatocyte, Kupffer cell, and endothelial cell isolation
Livers were perfused via the inferior vena cava, followed by collagenase digestion, centrifugation, and Percoll gradient centrifugation to obtain viable hepatocytes and nonparenchymal cell fractions as previously described. 9 Liver endothelial cells and Kupffer cells (>99% purity)
were isolated from the nonparenchymal cell fraction by fluorescenceactivated cell sorting (FACS) as previously described. 9 
| Immunoblot
Liver lysates were prepared, electrophoretically separated on a 10%
polyacrylamide gel, and transferred to nitrocellulose as previously described. 26 Blots were incubated with blocking buffer (5% nonfat dry milk in TBST) containing rabbit anti-Smad5 (1:1000; Abcam ab40771), rabbit anti-P-Smad5 (1:500; Abcam ab92698, hereafter called PSmad1/5 antibody due to crossreactivity with P-Smad1) overnight at 48C. Antibodies were verified previously. 26 Membranes were washed, incubated with the appropriate HRP-conjugated secondary antibodies, and immunoreactivity was visualized by enhanced chemiluminescence (SuperSignal West Pico; Pierce) and X-ray film. Chemiluminescence quantitation of scanned films was performed using ImageJ 1.46v.
| Statistics
Statistical significance was determined by 2-tailed Student's t-test or one-way analysis of variance (ANOVA) with Dunnett's or Tukey's post hoc test for pairwise multiple comparisons using Prism 7 (GraphPad).
P < .05 was considered significant.
| R E SU LTS
3.1 | Iron increases liver hepcidin expression and Smad1/5 phosphorylation in Bmp6-/-mice A previous publication reported that dietary iron loading still induces hepcidin expression in iron depleted Bmp6-/-mice, although to a lesser extent than wildtype mice. 19 However, the mechanism for this residual hepcidin induction by iron in Bmp6-/-mice is not known. To confirm this finding in our Bmp6-/-mice generated by a different strategy, 9 we tested the effects of maintaining Bmp6-/-mice on an iron deficient diet (2-6 ppm iron) for 4 weeks after weaning, compared with switching mice to a standard rodent diet (which is high in iron, 380 ppm) for the last 1 week prior to sacrifice. Bmp6-/-mice switched to the standard diet had significantly increased serum iron and transferrin saturation compared to low iron diet mice ( Figure 1A ,B, left 2 bars), demonstrating iron loading by the standard diet. Liver hepcidin (Hamp) mRNA was also significantly induced by dietary iron loading in Bmp6-/-mice ( Figure 1C , left 2 bars), similar to the prior report. 19 Notably, phosphorylation of liver Smad1/5
proteins (P-Smad1/5) was also induced by dietary iron loading in parallel with hepcidin in Bmp6-/-mice ( Figure 1D ). Together, these data confirm that there is another pathway for iron to induce hepcidin in the absence of BMP6, and suggest that this pathway may involve activation of SMAD signaling by another BMP ligand.
| BMP2/4 neutralizing antibody inhibits hepcidin induction by iron and increases liver iron loading in
Bmp6-/-mice
We previously demonstrated by surface plasmon resonance that HJV, the BMP co-receptor required for optimal hepcidin expression, has a high binding affinity not only for BMP6 (8.1 nM), but also for BMP2
and BMP4 (9.4 and 4.5 nM respectively). 20 HJV also binds to BMP5
and BMP7, although with lower affinity. 20 To investigate whether other BMP ligands, in particular BMP2 and/or BMP4, mediate hepcidin induction by iron in Bmp6-/-mice, we tested the ability of a neutralizing BMP2/4 antibody to inhibit hepcidin induction by dietary iron loading in Bmp6-/-mice. The efficacy and specificity of the BMP2/4 antibody was first examined in hepatoma-derived Hep3B cells using a hepcidin promoter luciferase reporter assay. 7 The BMP2/4 antibody potently inhibited hepcidin promoter luciferase activity induced by either BMP2
or BMP4 ( Figure 1E ). However, at higher concentrations, this antibody also inhibited hepcidin promoter luciferase activity induced by other BMP ligands, including BMP5, BMP7, a BMP2/6 heterodimer, and, to a lesser extent, BMP6 ( Figure 1E ). BMP2/4 antibody did not inhibit
BMP9 at the highest concentrations tested ( Figure 1E ) or other TGF-b super family members tested, including Activin B (data not shown).
Next, we placed Bmp6-/-mice at weaning on a low iron diet for 3
weeks, followed by a standard diet in combination with the neutralizing BMP2/4 antibody or vehicle alone (PBS) for 1 week. The BMP2/4 antibody completely inhibited the induction of both P-Smad1/5 ( Figure 1F) and Hamp by dietary iron loading ( Figure 1C , compare right 2 bars).
Blockade of this residual hepcidin induction by iron was physiologically relevant because it resulted in increased liver iron loading in BMP2/4
antibody treated mice compared with vehicle treated mice ( Figure 1G ), although serum iron, which was already high in Bmp6-/-mice, was not further increased ( Figure 1A,B) . Potential off-target effects of the BMP2/4 antibody to inhibit BMP6 were not relevant in this model where Bmp6 is ablated. These data support the hypothesis that hepcidin induction by iron in Bmp6-/-mice is dependent on other BMP ligands.
| BMP2/4 antibody, but not BMP4 antibody, inhibits hepcidin expression and induces iron loading in wildtype mice
To determine whether BMP2/4 antibody inhibits hepcidin expression under control conditions when BMP6 is present and to begin to determine the identity of the ligand involved, we treated 8-week-old wildtype mice with BMP2/4 antibody (10 mg/kg) or a specific neutralizing BMP4
antibody (10 mg/kg) daily for 3 days. Efficacy and specificity of the BMP4 antibody was confirmed by hepcidin promoter luciferase reporter assay ( Figure 2A ). We were unable to validate a commercial antibody that specifically neutralized BMP2 activity without impacting BMP4 activity (data not shown). We found that BMP2/4 antibody, but not 
| BMP2 is predominantly expressed in endothelial cells in the liver
To definitively establish whether BMP2 plays a role in hepcidin and iron homeostasis, we sought to develop a genetic mouse model. However, in contrast to Bmp6, Bmp2 global knockout mice are embryonic lethal. 27 We therefore determined the cellular source of Bmp2 in the liver using our previously described method to isolate highly purified hepatocytes, endothelial cells, and Kupffer cells (liver macrophages)
from mouse livers using a FACS based approach, 9 followed by measurement of Bmp2 mRNA expression by qRT-PCR. We found that similar to Bmp6, endothelial cells are the predominant source of Bmp2 mRNA in the liver ( Figure 2H,I ).
FIG URE 1 Dietary iron loading induces liver hepcidin expression and Smad phosphorylation in Bmp6
-/-mice, effects that are blocked by a neutralizing BMP2/4 antibody. Bmp6 -/-mice were fed a low iron diet for 3 weeks upon weaning, and then kept on the low iron diet or switched to a standard diet for 1 week, either alone or in combination with 10 mg/kg neutralizing BMP2/4 antibody (aBmp2/4) IP dosed every other day or an equal volume of vehicle alone (PBS). Mice were analyzed for serum iron (A), transferrin (Tf) saturation (B), liver hepcidin (Hamp) relative to Rpl19 mRNA expression by qRT-PCR (C), liver phosphorylated Smad1/5 (P-Smad1/5) relative to total Smad5 by immunoblot and chemiluminescence quantitation (D, F), and liver iron content (G). n 5 5-11 males (circles) and 3-6 females (triangles) per group in panels A, B, C, G. A subset of 5 mice per group was analyzed in panels D, F. Bars represent mean 6 SEM. For qRT-PCR experiments, the average of low iron diet mice was set to 1. * P < .05, ** P < .01, ***P < .001 relative to the low iron diet or PBS group by Student's t test. (E) Hep3B cells were transfected with a hepcidin promoter firefly luciferase reporter and pRL-TK Renilla luciferase control reporter, followed by treatment without or with 50 ng/ml BMP2, BMP4, BMP2/6, BMP6, BMP5, BMP7, or 5 ng/ml BMP9 for 16 hours in combination with 0 to 30 mg/ml aBMP2/4. Hamp mRNA and induces iron loading in wildtype mice. (A) Hep3B cells were transfected with a hepcidin promoter firefly luciferase reporter and pRL-TK Renilla luciferase control reporter, followed by treatment without or with 50 ng/ml BMP2, BMP4, BMP2/6, BMP6, BMP5, BMP7, or 5 ng/ml BMP9 for 16 hours in combination with 0 to 30 mg/ml neutralizing BMP4 antibody (aBMP4). Relative luciferase activity was analyzed as in Figure 1E . Values represent mean 6 SEM of 2 experiments, each performed in triplicate. (B-E) Eight-week-old male wildtype mice received an IP injection of 10 mg/kg aBmp2/4, 10 mg/kg aBmp4, or PBS alone daily for 3 days. Animals were analyzed for liver Hamp relative to Rpl19 mRNA expression by qRT-PCR (B), spleen iron content (C), serum iron (D), and liver iron content (E). (F-G) Eight-week-old male wildtype mice were injected with 20 mg/kg aBmp4 or PBS alone daily for 3 days. Animals were analyzed for liver Hamp relative to Rpl19 mRNA expression by qRT-PCR (F) and serum iron (G). (B-G) n 5 4-6 mice per group. Bars represent mean 6 SEM. For qRT-PCR results, the average of PBS treated mice was set to 1. ** P < .01, ***P < .001 relative to the PBS group by one-way ANOVA with Dunnett's post hoc
test (B-E) or Student's t test (F-G). (H-I) Hepatocytes (Hepa), endothelial cells (EC), and Kupffer cells (KC)
were isolated from wildtype male mouse livers (n 5 3 mice) and analyzed for Bmp2 (H) and Bmp6 mRNA (I) by qRT-PCR. Transcripts were normalized to Rpl19 and the average expression from KCs was set to 1. Bars represent mean 6 SEM. ***P versus Bmp6 copy number showed that Bmp2 mRNA is 11.6-fold higher compared with Bmp6 mRNA on an iron sufficient diet (40 ppm), but only 2.9-fold higher on a 1% carbonyl iron diet (10,000 ppm, Figure 4D ).
Thus, although both Bmp2 and Bmp6 mRNA levels are regulated by iron, the higher baseline expression of Bmp2 and higher induction of Bmp6 by iron lead to a different ratio of Bmp2 to Bmp6 under conditions of different iron status.
| D I SCUSSION
Inappropriate hepcidin regulation leads to several disorders of iron homeostasis including hemochromatosis, iron loading anemias, iron refractory iron deficiency anemia, and anemia of inflammation. 1, 6 The BMP-SMAD pathway is a central regulator of hepcidin expression in the liver. 29 Mutations in BMP-SMAD pathway components and modifiers of this pathway have a role in the pathogenesis of many of these iron disorders, [7] [8] [9] [12] [13] [14] [15] [16] [17] [18] 29 and pharmacologic BMP-SMAD pathway modulators have shown efficacy in treating some of these disorders in animal models. [30] [31] [32] Identifying the specific components of the BMP-SMAD pathway crucial for hepcidin regulation may help to elucidate the pathophysiology of iron disorders and yield new treatment targets.
We and others previously demonstrated that BMP6 is a key endogenous regulator of hepcidin expression and systemic iron homeostasis since Bmp6-/-mice have a hemochromatosis phenotype manifest by hepcidin deficiency, serum iron overload, and massive tissue iron loading in the liver, heart, and pancreas with reduced spleen iron content. analyzed for total liver Bmp6 relative to Rpl19 mRNA by qRT-PCR. n 5 4-13 mice per gender per group. Bars represent mean 6 SEM. The average of Cre-mice for each gender was set to 1. ***P < .001 relative to the respective Cre-controls by Student's t test. (B-C) C57BL/6 male mice were treated with a standard diet (380 ppm, Ctrl) compared to a low iron diet (2-6 ppm, B) or high iron diet (2% carbonyl iron, 20,000 ppm, C) for 3 weeks followed by analysis of total liver Bmp2 and Bmp6 mRNA relative to Rpl19 expression by qRT-PCR. n 5 6-12 mice per group. Bars represent mean 6 SEM. The average of standard diet mice was set to 1. **P < .01, ***P < .001 relative to standard diet mice by Student's t test. (D) Liver endothelial cells were isolated by FACS from 129S6/SvEvTac male mice treated with an iron sufficient diet (40 ppm) or a 1% carbonyl iron supplemented diet (10,000 ppm) for 4 weeks, and Bmp2 and Bmp6 copy numbers were quantitated by qRT-PCR. Fold difference in Bmp2 relative to Bmp6 copy number for each diet is shown above bars. Fold change for each ligand on 1% carbonyl iron diet compared to iron sufficient diet is shown inside bars. n 5 4-6 mice per group. **P < .01, ***P < .001 for Bmp2 compared with Bmp6 expression for each diet [Color figure can be viewed at wileyonlinelibrary.com] ligands such as BMP2/6 is that BMP2 binds with higher affinity to type I receptors, whereas BMP6 binds with higher affinity to type II heterodimer) plays a role is an interesting area for future study.
The ability of the neutralizing BMP2/4 antibody to completely block hepcidin induction by iron in Bmp6-/-mice suggests that hepcidin induction by iron is fully dependent on the BMP signaling pathway. An important limitation of the BMP2/4 neutralizing antibody is that it is not specific for inhibiting BMP2 and BMP4 ligands, but can also inhibit most other ligands, including BMP5, BMP7, BMP2/6, and, to a lesser extent, BMP6. A functional role for BMP2 is clearly established by the hemochromatosis phenotype of the Bmp2 conditional knockout mice. However, it is still possible that other BMP ligands contribute to hepcidin regulation in addition to BMP2 and BMP6. Indeed, we have previously demonstrated that many other BMP ligands can stimulate hepcidin expression when added exogenously, including BMP4, BMP5, BMP7, and BMP9. 37 Moreover, BMP4, BMP5, and BMP7 also bind to the coreceptor HJV that plays a critical role in hepcidin regulation in vivo.
20
A key role for BMP-SMAD signaling in hepcidin regulation in humans is supported by the fact that mutations in the BMP coreceptor HJV are a major cause of juvenile-onset hereditary hemochromatosis. 12 Although, evidence supporting a role for specific BMP ligands in humans is less robust than mice, heterozygous mutations in the BMP6 prodomain were recently linked to inappropriately low hepcidin levels and iron overload in humans. 38, 39 Additionally, a significant association between serum ferritin and a common SNP in the BMP2 gene has been reported in humans. 40 Finally, BMP2 was reported to contribute to hepcidin excess in multiple myeloma patients, 41 although this findings relied on the BMP2/4 neutralizing antibody that we have demonstrated is not specific for inhibiting BMP2 or BMP4. Our data raise possibility that mutations in BMP2 may function as another cause of hereditary hemochromatosis of a modifier of disease penetrance.
In summary, our findings reveal a crucial, non-redundant role for BMP2 in hepcidin and iron homeostasis regulation. These results may provide new insights into the pathophysiology of iron disorders and may help in the development of new more targeted therapies.
